LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR)
CUSIP: 514766104
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 37,508,353
- Total 13F shares
- 18,597,383
- Share change
- -1,208,877
- Total reported value
- $95,407,619
- Put/Call ratio
- 40%
- Price per share
- $5.13
- Number of holders
- 73
- Value change
- -$6,051,109
- Number of buys
- 40
- Number of sells
- 41
Quarterly Holders Quick Answers
What is CUSIP 514766104?
CUSIP 514766104 identifies LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 514766104:
Top shareholders of LFCR - LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WYNNEFIELD CAPITAL INC |
13F
|
Company |
13%
|
4,923,545
|
$26,144,024 | — | 31 Mar 2024 | |
| Legion Partners Asset Management, LLC |
13F
|
Company |
7.9%
|
2,950,227
|
$15,665,705 | — | 31 Mar 2024 | |
| Greenhaven Road Investment Management, L.P. |
13F
|
Company |
5.7%
|
2,144,018
|
$11,384,736 | — | 31 Mar 2024 | |
| 22NW, LP |
13F
|
Company |
4.7%
|
1,755,161
|
$9,319,905 | — | 31 Mar 2024 | |
| 325 CAPITAL LLC |
13F
|
Company |
3.6%
|
1,340,598
|
$7,118,575 | — | 31 Mar 2024 | |
| Cove Street Capital, LLC |
13F
|
Company |
3.4%
|
1,283,780
|
$6,816,872 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.2%
|
1,184,856
|
$6,291,585 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
2.1%
|
791,807
|
$4,204,496 | — | 31 Mar 2024 | |
| James G. Hall |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
276,096
|
$2,876,920 | — | 01 Jun 2023 | |
| Visionary Wealth Advisors |
13F
|
Company |
1.3%
|
496,779
|
$2,637,896 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.3%
|
478,816
|
$2,542,513 | — | 31 Mar 2024 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.94%
|
352,707
|
$1,872,874 | — | 31 Mar 2024 | |
| TOCQUEVILLE ASSET MANAGEMENT L.P. |
13F
|
Company |
0.94%
|
351,700
|
$1,867,527 | — | 31 Mar 2024 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.84%
|
315,719
|
$1,676,468 | — | 31 Mar 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.79%
|
295,587
|
$1,569,567 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.77%
|
286,962
|
$1,524,112 | — | 31 Mar 2024 | |
| DCF Advisers, LLC |
13F
|
Company |
0.76%
|
284,684
|
$1,511,672 | — | 31 Mar 2024 | |
| John D. Morberg |
3/4/5
|
Chief Financial Officer |
—
class O/S missing
|
125,617
|
$1,308,929 | — | 18 Jan 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.45%
|
167,095
|
$887,274 | — | 31 Mar 2024 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.43%
|
160,233
|
$850,837 | — | 31 Mar 2024 | |
| 272 Capital LP |
13F
|
Company |
0.39%
|
145,459
|
$772,387 | — | 31 Mar 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.38%
|
143,279
|
$760,811 | — | 31 Mar 2024 | |
| Albert D. Bolles |
3/4/5
|
Chief Executive Officer |
—
class O/S missing
|
72,883
|
$759,441 | — | 23 May 2022 | |
| Laurion Capital Management LP |
13F
|
Company |
0.35%
|
131,583
|
$698,706 | — | 31 Mar 2024 | |
| CITIGROUP INC |
13F
|
Company |
0.34%
|
128,552
|
$682,612 | — | 31 Mar 2024 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.34%
|
127,000
|
$674,000 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.32%
|
120,957
|
$642,282 | — | 31 Mar 2024 | |
| Tonia L. Pankopf |
3/4/5
|
Director |
—
class O/S missing
|
59,599
|
$621,022 | — | 04 Jun 2022 | |
| Catherine A. Sohn |
3/4/5
|
Director |
—
class O/S missing
|
54,069
|
$563,399 | — | 04 Jun 2022 | |
| Man Group plc |
13F
|
Company |
0.26%
|
99,124
|
$526,348 | — | 31 Mar 2024 | |
| Quinn Opportunity Partners LLC |
13F
|
Company |
0.25%
|
94,813
|
$503,457 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.23%
|
87,701
|
$465,692 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.21%
|
76,900
|
$408,339 | — | 31 Mar 2024 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.2%
|
76,200
|
$404,622 | — | 31 Mar 2024 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
0.2%
|
75,610
|
$401,489 | — | 31 Mar 2024 | |
| Deborah D. Carosella |
3/4/5
|
Director |
—
class O/S missing
|
36,588
|
$381,247 | — | 04 Jun 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.19%
|
70,104
|
$372,252 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.16%
|
61,650
|
$327,361 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.16%
|
59,495
|
$315,918 | — | 31 Mar 2024 | |
| Andrew Kenneth William Powell |
3/4/5
|
Director |
—
class O/S missing
|
27,477
|
$286,310 | — | 04 Jun 2022 | |
| Diversified Trust Co |
13F
|
Company |
0.12%
|
46,062
|
$244,589 | — | 31 Mar 2024 | |
| Timothy P. Burgess |
3/4/5
|
Senior VP of Supply Chain |
—
mixed-class rows
|
30,000
mixed-class rows
|
$239,704 | — | 27 Jul 2021 | |
| OPPENHEIMER ASSET MANAGEMENT INC. |
13F
|
Company |
0.11%
|
43,001
|
$228,335 | — | 31 Mar 2024 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.1%
|
37,367
|
$198,419 | — | 31 Mar 2024 | |
| Brevan Howard Capital Management LP |
13F
|
Company |
0.09%
|
32,785
|
$174,088 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
24,789
|
$131,630 | — | 31 Mar 2024 | |
| Y-Intercept (Hong Kong) Ltd |
13F
|
Company |
0.07%
|
24,552
|
$130,371 | — | 31 Mar 2024 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.06%
|
23,852
|
$126,654 | — | 31 Mar 2024 | |
| Keene & Associates, Inc. |
13F
|
Company |
0.06%
|
22,410
|
$118,997 | — | 31 Mar 2024 | |
| Marathon Trading Investment Management LLC |
13F
|
Company |
0.05%
|
19,900
|
$105,669 | — | 31 Mar 2024 |
Institutional Holders of LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) as of Q2 2024
As of 30 Jun 2024,
LIFECORE BIOMEDICAL, INC. \DE\ - Common Stock (LFCR) was held by
73 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,597,383 shares.
The largest 10 holders included
WYNNEFIELD CAPITAL INC, Legion Partners Asset Management, LLC, Greenhaven Road Investment Management, L.P., BlackRock Inc., 325 CAPITAL LLC, VANGUARD GROUP INC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, Visionary Wealth Advisors, and DEUTSCHE BANK AG\.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
75
Q2 2024 holders
73
Holder diff
-2
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.